Search | Page 3 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Pathophysiology and management of thrombocytopenia in bone marrow failure: possible clinical applications of thrombopoietin receptor agonists in aplastic anemia and myelodysplastic syndromes.

    ... in 9/11 patients. No increase in bone marrow blasts, fibrosis , or leukemia was observed in the patients. With these promising ...

    Research Review last updated 05/02/2016 - 9:21am.

  2. Randomized Trial of Pegylated Interferon Alfa-2a Versus Hydroxyurea in Polycythemia Vera (PV) and Essential Thrombocythemia (ET)

    ... may have up to and including 2+ marrow reticulin fibrosis (0, 1 or 2 on scale 0 -4).     Not meeting WHO criteria for ...

    Clinical Trial last updated 05/02/2016 - 2:31pm.

  3. Pegylated Interferon Alfa-2a Salvage Therapy in High Risk Polycythemia Vera (PV) or Essential Thrombocythemia (ET)

    ... may have up to and including 2+ marrow reticulin fibrosis . Not meeting WHO criteria for CML, PV, MDS, PMF or over ...

    Clinical Trial last updated 04/29/2016 - 9:59am.

  4. Selective Depletion of CD45RA+ Naive T Cells From Allogeneic Peripheral Blood Stem Cell Grafts From HLA-Matched Related and Unrelated Donors for Prevention of GVHD

    ... with evidence of portal hypertension or bridging fibrosis , alcoholic hepatitis, esophageal varices, a history of bleeding ...

    Clinical Trial last updated 06/06/2016 - 2:55pm.

  5. Extended Dosing With Eltrombopag for Severe Aplastic Anemia

    ... hematopoiesis in responders, without increased fibrosis . In the previous study, response assessment occurred at 12 ...

    Clinical Trial last updated 04/26/2016 - 9:36am.

  6. The Pathologist’s Role in an MDS Diagnosis

    ... are situations where the MDS may be associated with fibrosis , and distinction from myelofibrosis or ...

    Interview last updated 01/28/2014 - 1:47pm.